Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |